BACKGROUND AND PURPOSE: To our knowledge, no published studies have examined whole-brain regional differences to identify more discrete volumetric changes in the brains of childhood leukemia survivors. We used voxel-based morphometry (VBM) to examine regional gray and white matter differences in a group of long-term survivors of acute lymphoblastic leukemia (ALL) compared with a group of healthy controls. Differences in regional white matter volume were expected, given previous reports of white matter changes during treatment for ALL and reduced brain white matter volumes in long-term survivors. Follow-up analyses examined the relationship of regional brain volumes to cognitive function. MATERIALS AND METHODS: We compared 9 long-term survivors of ALL with 14 healthy controls. Survivors of ALL were treated with systemic and intrathecal chemotherapy only. T1-weighted axial 3D spoiled gradient high-resolution images collected on a 1.5T MR imaging scanner were used for the VBM analysis. Neuropsychological evaluations were conducted within 2 months of the MR imaging to assess cognitive function. RESULTS: VBM analysis revealed 2 specific regions of reduced white matter in the right frontal lobes of survivors of ALL compared with healthy controls. Survivors of ALL had lower performances on tests of attention, visual-constructional skills, mental flexibility, and math achievement compared with healthy individuals. Decreased performance on neuropsychological measures was associated with decreased regional white matter volumes. No differences were found between the groups with respect to gray matter regions. CONCLUSION: These findings are consistent with previous literature describing the long-term cognitive, academic, and imaging findings of survivors of ALL and suggest that right frontal white matter is particularly vulnerable to disruption following intensive chemotherapy for ALL. Future studies should focus on further clarifying the white matter changes observed.
BACKGROUND AND PURPOSE: To our knowledge, no published studies have examined whole-brain regional differences to identify more discrete volumetric changes in the brains of childhood leukemia survivors. We used voxel-based morphometry (VBM) to examine regional gray and white matter differences in a group of long-term survivors of acute lymphoblastic leukemia (ALL) compared with a group of healthy controls. Differences in regional white matter volume were expected, given previous reports of white matter changes during treatment for ALL and reduced brain white matter volumes in long-term survivors. Follow-up analyses examined the relationship of regional brain volumes to cognitive function. MATERIALS AND METHODS: We compared 9 long-term survivors of ALL with 14 healthy controls. Survivors of ALL were treated with systemic and intrathecal chemotherapy only. T1-weighted axial 3D spoiled gradient high-resolution images collected on a 1.5T MR imaging scanner were used for the VBM analysis. Neuropsychological evaluations were conducted within 2 months of the MR imaging to assess cognitive function. RESULTS: VBM analysis revealed 2 specific regions of reduced white matter in the right frontal lobes of survivors of ALL compared with healthy controls. Survivors of ALL had lower performances on tests of attention, visual-constructional skills, mental flexibility, and math achievement compared with healthy individuals. Decreased performance on neuropsychological measures was associated with decreased regional white matter volumes. No differences were found between the groups with respect to gray matter regions. CONCLUSION: These findings are consistent with previous literature describing the long-term cognitive, academic, and imaging findings of survivors of ALL and suggest that right frontal white matter is particularly vulnerable to disruption following intensive chemotherapy for ALL. Future studies should focus on further clarifying the white matter changes observed.
Authors: Laura Iuvone; Paolo Mariotti; Cesare Colosimo; Francesco Guzzetta; Antonio Ruggiero; Riccardo Riccardi Journal: Cancer Date: 2002-12-15 Impact factor: 6.860
Authors: Wilburn E Reddick; Zuyao Y Shan; John O Glass; Susan Helton; Xiaoping Xiong; Shengjie Wu; Melanie J Bonner; Scott C Howard; Robbin Christensen; Raja B Khan; Ching-Hon Pui; Raymond K Mulhern Journal: Cancer Date: 2006-02-15 Impact factor: 6.860
Authors: Lyndsay A Harshman; Sheila Barron; Anna M Button; Brian J Smith; Brian K Link; Charles F Lynch; Natalie L Denburg Journal: J Pediatr Psychol Date: 2012-01-23
Authors: Laura K Campbell; Mary Scaduto; Deborah Van Slyke; Frances Niarhos; James A Whitlock; Bruce E Compas Journal: J Pediatr Psychol Date: 2008-07-30
Authors: Michelle N Edelmann; Kevin R Krull; Wei Liu; John O Glass; Qing Ji; Robert J Ogg; Noah D Sabin; Deo Kumar Srivastava; Leslie L Robison; Melissa M Hudson; Wilburn E Reddick Journal: Brain Date: 2014-08-13 Impact factor: 13.501
Authors: Heather M Conklin; Robert J Ogg; Jason M Ashford; Matthew A Scoggins; Ping Zou; Kellie N Clark; Karen Martin-Elbahesh; Kristina K Hardy; Thomas E Merchant; Sima Jeha; Lu Huang; Hui Zhang Journal: J Clin Oncol Date: 2015-10-12 Impact factor: 44.544
Authors: Kristen E Robinson; Katherine L Livesay; Laura K Campbell; Mary Scaduto; Christopher J Cannistraci; Adam W Anderson; James A Whitlock; Bruce E Compas Journal: Pediatr Blood Cancer Date: 2010-04 Impact factor: 3.167
Authors: Ping Zou; Yimei Li; Heather M Conklin; Raymond K Mulhern; Robert W Butler; Robert J Ogg Journal: Arch Clin Neuropsychol Date: 2012-10-18 Impact factor: 2.813
Authors: Joshua E Caron; Kevin R Krull; Marilyn Hockenberry; Neelam Jain; Kris Kaemingk; Ida M Moore Journal: Pediatr Blood Cancer Date: 2009-10 Impact factor: 3.167
Authors: Mary Baron Nelson; Peggy Compton; Paul M Macey; Sunita K Patel; Eufemia Jacob; Sharon O'Neil; Jennifer Ogren; Jonathan L Finlay; Ronald M Harper Journal: J Pediatr Oncol Nurs Date: 2015-07-27 Impact factor: 1.636